References
- Beaconsfield P, Ginsburg J, Rainsbury R. Marihuana smoking. Cardiovascular effects in man and possible mechanisms. N Engl J Med. 1972;287(5):209–212.
- Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol. 2002;42(S1):58S–63S.
- Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol. 2002;42(S1):64S–70S.
- Johnson S, Domino EF. Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther. 1971; 12(5):762–768.
- Brancheau D, Blanco J, Gholkar G, et al. Cannabis induced asystole. J Electrocardiol. 2016;49(1):15–17.
- Heckle MR, Nayyar M, Sinclair SE, et al. Cannabinoids and symptomatic bradycardia. Am J Med Sci. 2018;355(1):3–5.
- Noble MJ, Hedberg K, Hendrickson RG. Acute cannabis toxicity. Clin Toxicol. 2019;57(8):735–742.
- Vollmer RR, Cavero I, Ertel RJ, et al. Role of the central autonomic nervous system in the hypotension and bradycardia induced by (-)-delta 9-trans-tetrahydrocannabinol. J Pharm Pharmacol. 1974;26(3):186–192.
- Fleming S, Thompson M, Stevens R, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377(9770):1011–1018.
- Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther. 1975;18(3):287–297.